ArticleAlimentary pharmacology & therapeutics2019

Letter: programmed cell death protein-1-targeted immunotherapy for advanced hepatocellular carcinoma-authors' reply.

Bernhard Scheiner et al.PubMed ↗Publisher ↗

No numbers read from the abstract.